The a2 Milk Company Limited logo

Notice pursuant to Listing Rule 7.12.1

Capital Change13 July 2018ATMConsumer Staples

ASX Code: A2M
NZX Code: ATM



Notice pursuant to NZX Main Board Listing Rule 7.12.1

In accordance with NZX Main Board Listing Rule 7.12.1, The a2 Milk Company Limited (ATM) advises that the

following securities have been issued on 13 July 2018:

Class of Security: Performance rights and time-based rights, each

representing an entitlement to acquire ordinary shares

in ATM

ISIN: Not applicable – the rights will not be listed on the NZX

Main Board or the ASX

Number issued: Performance rights – 245,787

Time-based rights – 599,254

Issue price: Not applicable

Payment in cash: Not applicable

Amount paid up (if not in full): Not applicable

Percentage of the total class of securities issued: 8.5% of performance rights; 100% of time-based rights

Reason for issue: The performance rights have been granted to the

incoming Chief Executive Officer of ATM as part of the

on-going long term incentive arrangements that ATM

has adopted to assist in the reward, retention and

motivation of its employees.

The time-based rights have been granted to the

incoming Chief Executive Officer of ATM on a one-off

basis as compensation for forfeitures of her former

employer's short term incentive and long-term incentive

entitlements as a result of her resigning to take up

employment with ATM.

Specific authority for issue: Board resolution

Terms or details of issue: Each performance right and each time-based right is

issued pursuant to the terms and conditions of ATM's

Long Term Incentive Plan (LTIP).


Upon vesting, each performance right and each time-

based right will entitle the holder to one ordinary share

in ATM.


Performance rights: Each performance right includes a

vesting condition that the participant must remain an

Employee (as defined in the LTIP Rules) up to and

including the vesting date (30 June 2021) and that ATM

achieves a compound annual growth rate in diluted

earnings per share (CAGR) from the beginning of the

financial year ending 30 June 2019 to the end of the

financial year ending 30 June 2021 of at least 15%.

ASX Code: A2M
NZX Code: ATM


The proportion of performance rights that will vest will

be determined on a straight-line basis between the

following parameters (rounded down to the nearest

whole number):

• 50% of the performance rights will vest if a CAGR of

15% is achieved; or

• 100% of the performance rights will vest if a CAGR of

25% or more is achieved.


Time-based rights: Each time-based right is not subject

to performance hurdles but includes a vesting condition

that the participant must remain an Employee (as

defined in the LTIP Rules) up to and including one of four

vesting dates during the period from 28 August 2018 to

24 August 2019


Total number of securities of the class

in existence after the issue: 960,000 performance rights issued on 17 August 2015,

895,000 performance rights issued on 8 February 2017,

87,000 performance rights issued on 10 March 2017,

406,000 performance rights issued on 27 September

2017 and 304,200 performance rights issued on 6 March

2018, 245,787 performance rights issued on 13 July 2018

599,254 time-based rights issued on 13 July 2018

Treasury stock (acquisition only): Not applicable

Date of issue: 13 July 2018


Geoffrey Babidge

Managing Director

The a2 Milk Company Limited

+61 2 9697 7000

---

Appendix 3B
New issue announcement




+ See chapter 19 for defined terms.


04/03/2013 Appendix 3B Page 1

Rule 2.7, 3.10.3, 3.10.4, 3.10.5

Appendix 3B


New issue announcement,

application for quotation of additional securities

and agreement


Information or documents not available now must be given to ASX as soon as available. Information and

documents given to ASX become ASX’s property and may be made public.

Introduced 01/07/96 Origin: Appendix 5 Amended 01/07/98, 01/09/99, 01/07/00, 30/09/01, 11/03/02, 01/01/03, 24/10/05, 01/08/12,

04/03/13


Name of entity

The a2 Milk Company Limited


ABN

97 769 415 292


We (the entity) give ASX the following information.


Part 1 - All issues

You must complete the relevant sections (attach sheets if there is not enough space).


1

+

Class of

+

securities issued or to

be issued

Performance rights and time-based rights,

each representing an entitlement to acquire

ordinary shares in the entity.



2

Number of

+

securities issued or to

be issued (if known) or maximum

number which may be issued

Performance rights – 245,787


Time-based rights – 599,254



3

Principal terms of the

+

securities

(e.g. if options, exercise price and

expiry date; if partly paid

+

securities, the amount

outstanding and due dates for

payment; if

+

convertible

securities, the conversion price

and dates for conversion)

Each performance right and each time-based

right is issued pursuant to the terms and

conditions of the entity's Long Term Incentive

Plan (LTIP).


Upon vesting, each performance right and

each time-based right will entitle the holder

to one ordinary share in the entity.


Performance rights


Each performance right includes a vesting

condition that the participant must remain an

Appendix 3B
New issue announcement




+ See chapter 19 for defined terms.


Appendix 3B Page 2 04/03/2013

Employee (as defined in the LTIP Rules) up to

and including the vesting date (30 June 2021)

and that the entity achieves a compound

annual growth rate in diluted earnings per

share (CAGR) from the beginning of the

financial year ending 30 June 2019 to the end

of the financial year ending 30 June 2021 of at

least 15%.


The proportion of performance rights that will

vest will be determined on a straight-line basis

between the following parameters (rounded

down to the nearest whole number):


• 50% of the performance rights will vest if a

CAGR of 15% is achieved; or


• 100% of the performance rights will vest if

a CAGR of 25% or more is achieved.


Time-based rights


Each time-based right is not subject to

performance hurdles but includes a vesting

condition that the participant must remain an

Employee (as defined in the LTIP Rules) up to

and including one of four vesting dates during

the period from 28 August 2018 to 24 August

2019.



4

Do the

+

securities rank equally in

all respects from the

+

issue date

with an existing

+

class of quoted

+

securities?


If the additional

+

securities do not

rank equally, please state:

• the date from which they do

• the extent to which they

participate for the next

dividend, (in the case of a

trust, distribution) or interest

payment

• the extent to which they do not

rank equally, other than in

relation to the next dividend,

distribution or interest

payment

No.


Any shares issued upon vesting of a

performance right or a time-based right will

rank equally in all respects with the existing

class of quoted ordinary shares from the date

of allotment and issue of those shares.


Appendix 3B
New issue announcement




+ See chapter 19 for defined terms.


04/03/2013 Appendix 3B Page 3

5 Issue price or consideration

Nil.



6 Purpose of the issue

(If issued as consideration for the

acquisition of assets, clearly

identify those assets)

The performance rights have been granted to

the incoming Chief Executive Officer of the

entity as part of the on-going long term

incentive arrangements that the entity has

adopted to assist in the reward, retention and

motivation of its employees.


The time-based rights have been granted to

the incoming Chief Executive Officer of the

entity on a one-off basis as compensation for

forfeitures of her former employer's short

term incentive and long-term incentive

entitlements as a result of her resigning to

take up employment with the entity.



6a

Is the entity an

+

eligible entity

that has obtained security holder

approval under rule 7.1A?


If Yes, complete sections 6b – 6h

in relation to the

+

securities the

subject of this Appendix 3B, and

comply with section 6i

No.



6b The date the security holder

resolution under rule 7.1A was

passed

n/a



6c

Number of

+

securities issued

without security holder approval

under rule 7.1

n/a



6d

Number of

+

securities issued with

security holder approval under

rule 7.1A

n/a



6e

Number of

+

securities issued with

security holder approval under

rule 7.3, or another specific

security holder approval (specify

date of meeting)

n/a


Appendix 3B
New issue announcement




+ See chapter 19 for defined terms.


Appendix 3B Page 4 04/03/2013

6f

Number of

+

securities issued

under an exception in rule 7.2

n/a



6g

If

+

securities issued under rule

7.1A, was issue price at least 75%

of 15 day VWAP as calculated

under rule 7.1A.3? Include the

+

issue date and both values.

Include the source of the VWAP

calculation.

n/a



6h

If

+

securities were issued under

rule 7.1A for non-cash

consideration, state date on which

valuation of consideration was

released to ASX Market

Announcements

n/a



6i Calculate the entity’s remaining

issue capacity under rule 7.1 and

rule 7.1A – complete Annexure 1

and release to ASX Market

Announcements

n/a



7

+

Issue dates

Note: The issue date may be prescribed by ASX

(refer to the definition of issue date in rule 19.12).

For example, the issue date for a pro rata

entitlement issue must comply with the

applicable timetable in Appendix 7A.

Cross reference: item 33 of Appendix 3B.

13 July 2018




Number

+

Class

8

Number and

+

class of all

+

securities quoted on ASX

(including the

+

securities in

section 2 if applicable)

730,039,067 fully paid ordinary shares


Appendix 3B
New issue announcement




+ See chapter 19 for defined terms.


04/03/2013 Appendix 3B Page 5


Number

+

Class

9

Number and

+

class of all

+

securities not quoted on ASX

(including the

+

securities in

section 2 if applicable)

9,100,998



3,300,000



1,500,000


960,000


895,000


87,000


406,000



304,200


245,787


599,254

options issued on

17 August 2015 with an

exercise price of NZ$0.63

options issued on

30 March 2015 with an

exercise price of NZ$0.63

partly paid ordinary

shares

performance rights

issued on 17 August 2015

performance rights

issued on 8 February 2017

performance rights

issued on 10 March 2017

performance rights

issued on 28 September

2017

performance rights

issued on 6 March 2018

performance rights

issued on 13 July 2018

time-based rights issued

on 13 July 2018



10 Dividend policy (in the case of a

trust, distribution policy) on the

increased capital (interests)

n/a


Part 2 - Pro rata issue


11 Is security holder approval

required?

n/a



12 Is the issue renounceable or non-

renounceable?

n/a



13

Ratio in which the

+

securities will

be offered

n/a



14

+

Class of

+

securities to which the

offer relates

n/a


Appendix 3B
New issue announcement




+ See chapter 19 for defined terms.


Appendix 3B Page 6 04/03/2013

15

+

Record date to determine

entitlements

n/a



16 Will holdings on different registers

(or subregisters) be aggregated for

calculating entitlements?

n/a



17 Policy for deciding entitlements in

relation to fractions

n/a



18 Names of countries in which the

entity has security holders who will

not be sent new offer documents

Note: Security holders must be told how their

entitlements are to be dealt with.

Cross reference: rule 7.7.

n/a



19 Closing date for receipt of

acceptances or renunciations

n/a



20 Names of any underwriters

n/a



21 Amount of any underwriting fee or

commission

n/a



22 Names of any brokers to the issue

n/a



23 Fee or commission payable to the

broker to the issue

n/a



24 Amount of any handling fee

payable to brokers who lodge

acceptances or renunciations on

behalf of security holders

n/a



25 If the issue is contingent on

security holders’ approval, the date

of the meeting

n/a


Appendix 3B
New issue announcement




+ See chapter 19 for defined terms.


04/03/2013 Appendix 3B Page 7

26 Date entitlement and acceptance

form and offer documents will be

sent to persons entitled

n/a



27 If the entity has issued options,

and the terms entitle option

holders to participate on exercise,

the date on which notices will be

sent to option holders

n/a



28 Date rights trading will begin (if

applicable)

n/a



29 Date rights trading will end (if

applicable)

n/a



30 How do security holders sell their

entitlements in full through a

broker?

n/a



31 How do security holders sell part

of their entitlements through a

broker and accept for the balance?

n/a



32 How do security holders dispose of

their entitlements (except by sale

through a broker)?

n/a



33

+

Issue date

n/a




Part 3 - Quotation of securities

You need only complete this section if you are applying for quotation of securities


34

Type of

+

securities

(tick one)

(a)


+

Securities described in Part 1


(b)


All other

+

securities

Example: restricted securities at the end of the escrowed period, partly paid securities that become fully paid,

employee incentive share securities when restriction ends, securities issued on expiry or conversion of convertible

securities

Appendix 3B
New issue announcement




+ See chapter 19 for defined terms.


Appendix 3B Page 8 04/03/2013

Entities that have ticked box 34(a)


Additional securities forming a new class of securities


Tick to indicate you are providing the information or

documents



35


If the

+

securities are

+

equity securities, the names of the 20 largest holders of the

additional

+

securities, and the number and percentage of additional

+

securities

held by those holders



36


If the

+

securities are

+

equity securities, a distribution schedule of the additional

+

securities setting out the number of holders in the categories

1 - 1,000

1,001 - 5,000

5,001 - 10,000

10,001 - 100,000

100,001 and over



37


A copy of any trust deed for the additional

+

securities


Entities that have ticked box 34(b)


38

Number of

+

securities for which

+

quotation is sought





39

+

Class of

+

securities for which

quotation is sought




40

Do the

+

securities rank equally in

all respects from the

+

issue date

with an existing

+

class of quoted

+

securities?


If the additional

+

securities do not

rank equally, please state:

• the date from which they do

• the extent to which they

participate for the next

dividend, (in the case of a trust,

distribution) or interest

payment

• the extent to which they do not

rank equally, other than in

relation to the next dividend,

distribution or interest payment

Appendix 3B
New issue announcement




+ See chapter 19 for defined terms.


04/03/2013 Appendix 3B Page 9



41 Reason for request for quotation

now

Example: In the case of restricted securities, end of

restriction period


(if issued upon conversion of

another

+

security, clearly identify

that other

+

security)





Number

+

Class

42

Number and

+

class of all

+

securities

quoted on ASX (including the

+

securities in clause 38)


Appendix 3B
New issue announcement




+ See chapter 19 for defined terms.


Appendix 3B Page 10 04/03/2013

Quotation agreement


1

+

Quotation of our additional

+

securities is in ASX’s absolute discretion. ASX

may quote the

+

securities on any conditions it decides.


2 We warrant the following to ASX.


• The issue of the

+

securities to be quoted complies with the law and is

not for an illegal purpose.


• There is no reason why those

+

securities should not be granted

+

quotation.


• An offer of the

+

securities for sale within 12 months after their issue will

not require disclosure under section 707(3) or section 1012C(6) of the

Corporations Act.

Note: An entity may need to obtain appropriate warranties from subscribers for the securities in order to be able

to give this warranty


• Section 724 or section 1016E of the Corporations Act does not apply to

any applications received by us in relation to any

+

securities to be

quoted and that no-one has any right to return any

+

securities to be

quoted under sections 737, 738 or 1016F of the Corporations Act at the

time that we request that the

+

securities be quoted.


• If we are a trust, we warrant that no person has the right to return the

+

securities to be quoted under section 1019B of the Corporations Act at

the time that we request that the

+

securities be quoted.


3 We will indemnify ASX to the fullest extent permitted by law in respect of any

claim, action or expense arising from or connected with any breach of the

warranties in this agreement.


4 We give ASX the information and documents required by this form. If any

information or document is not available now, we will give it to ASX before

+

quotation of the

+

securities begins. We acknowledge that ASX is relying on

the information and documents. We warrant that they are (will be) true and

complete.



Sign here: ............................................................ Date:

(Director/Company secretary)


Print name:


== == == == ==

Appendix 3B
New issue announcement




+ See chapter 19 for defined terms.


04/03/2013 Appendix 3B Page 11

Appendix 3B – Annexure 1


Calculation of placement capacity under rule 7.1 and rule 7.1A

for eligible entities

Introduced 01/08/12 Amended 04/03/13


Part 1


Rule 7.1 – Issues exceeding 15% of capital

Step 1: Calculate “A”, the base figure from which the placement

capacity is calculated

Insert number of fully paid

+

ordinary

securities on issue 12 months before the

+

issue date or date of agreement to issue

n/a

Add the following:

• Number of fully paid

+

ordinary securities

issued in that 12 month period under an

exception in rule 7.2

• Number of fully paid

+

ordinary securities

issued in that 12 month period with

shareholder approval

• Number of partly paid

+

ordinary

securities that became fully paid in that

12 month period

Note:

• Include only ordinary securities here –

other classes of equity securities cannot

be added

• Include here (if applicable) the securities

the subject of the Appendix 3B to which

this form is annexed

• It may be useful to set out issues of

securities on different dates as separate

line items

n/a

Subtract the number of fully paid

+

ordinary

securities cancelled during that 12 month

period

n/a

“A” n/a

Appendix 3B
New issue announcement




+ See chapter 19 for defined terms.


Appendix 3B Page 12 04/03/2013

Step 2: Calculate 15% of “A”

“B” 0.15

[Note: this value cannot be changed]

Multiply “A” by 0.15 n/a

Step 3: Calculate “C”, the amount of placement capacity under rule

7.1 that has already been used

Insert number of

+

equity securities issued

or agreed to be issued in that 12 month

period not counting those issued:

• Under an exception in rule 7.2

• Under rule 7.1A

• With security holder approval under

rule 7.1 or rule 7.4

Note:

• This applies to equity securities, unless

specifically excluded – not just ordinary

securities

• Include here (if applicable) the

securities the subject of the Appendix

3B to which this form is annexed

• It may be useful to set out issues of

securities on different dates as

separate line items

n/a

“C” n/a

Step 4: Subtract “C” from [“A” x “B”] to calculate remaining

placement capacity under rule 7.1

“A” x 0.15

Note: number must be same as shown in

Step 2

n/a

Subtract “C”

Note: number must be same as shown in

Step 3

n/a

Total [“A” x 0.15] – “C” n/a

[Note: this is the remaining placement

capacity under rule 7.1]

Appendix 3B
New issue announcement




+ See chapter 19 for defined terms.


04/03/2013 Appendix 3B Page 13

Part 2


Rule 7.1A – Additional placement capacity for eligible entities

Step 1: Calculate “A”, the base figure from which the placement

capacity is calculated

“A”

Note: number must be same as shown in

Step 1 of Part 1

n/a

Step 2: Calculate 10% of “A”

“D” 0.10

Note: this value cannot be changed

Multiply “A” by 0.10 n/a

Step 3: Calculate “E”, the amount of placement capacity under rule

7.1A that has already been used

Insert number of

+

equity securities issued

or agreed to be issued in that 12 month

period under rule 7.1A

Notes:

• This applies to equity securities – not

just ordinary securities

• Include here – if applicable – the

securities the subject of the Appendix

3B to which this form is annexed

• Do not include equity securities issued

under rule 7.1 (they must be dealt with

in Part 1), or for which specific security

holder approval has been obtained

• It may be useful to set out issues of

securities on different dates as separate

line items

n/a

“E” n/a

Appendix 3B
New issue announcement




+ See chapter 19 for defined terms.


Appendix 3B Page 14 04/03/2013

Step 4: Subtract “E” from [“A” x “D”] to calculate remaining

placement capacity under rule 7.1A

“A” x 0.10

Note: number must be same as shown in

Step 2

n/a

Subtract “E”

Note: number must be same as shown in

Step 3

n/a

Total [“A” x 0.10] – “E” n/a

Note: this is the remaining placement

capacity under rule 7.1A

Data sourced from publicly available filings. Our datasets may not be complete. Automated analysis can produce errors. If you believe any data on this page is incorrect, please contact us at hello@nzxplorer.co.nz. For informational purposes only. Not investment advice.

Other issuers discussed similar conditions around this time

Matched by meaning across NZX announcement text, not keywords — based on our semantic index of announcement bodies.

  • AFT — AFT Pharmaceuticals Limited: NOTICE PURSUANT TO LISTING RULE 7.12.1
    2018-06-14

    15 June 2018 NOTICE PURSUANT TO LISTING RULE 7.12.1 For the purposes of Rule 7.12.1 of the NZX Main Board Listing Rules, AFT Pharmaceuticals Limited (NZX: AFT; ASX:AFP, the “Company”) advises that the following securities have been issued: a) Class of Security I…”

  • NZX — NZX Limited: CEO remuneration disclosure
    2018-05-11

    NZX Limited Level 1, NZX Centre 11 Cable Street PO Box 2959 Wellington 6140 New Zealand Tel +64 4 472 7599 www.nzx.com 11 May 2018 Notice of issue of performance rights which give the holder options to acquire ordinary shares under NZX Limited’s Long Term Incent…”

  • ANZ — ANZ Group Holdings Limited: Appendix 3B
    2018-07-04

    3 Principal terms of the + securities (e.g. if options, exercise price and expiry date; if partly paid + securities, the amount outstanding and due dates for payment; if + convertible securities, the conversion price and dates for conversion) 1…”